Pulmonx gets CE mark for emphysema device; DoD is focused on diagnostics;

 @FierceMedDev: Bacterin International, a maker of bone graft material and antimicrobial coatings, won $25M in financing from OrbiMed. Release | Follow @FierceMedDev

 @MarkHFierce: BSX is slashing more jobs and splitting its cardio business in two--undoing changes enacted by the old CEO. More | Follow @MarkHFierce

 @DamianFierce: Baxter is recalling four Automix devices over a deadly malfunction risk. The FDA has labeled it a Class I. News | Follow @DamianFierce

> Pulmonx got a CE mark for the Zephyr endobronchial valve, targeted to relieve hyperinflation associated with emphysema. More

> The Department of Defense is reaffirming its commitment to diagnostics, saying it wants to increase the use of in-the-field assays to keep soldiers safe. Story

> CareFusion ($CFN) is delaying filing its annual report to discuss the use of an alternative accounting method with the SEC. Article

> India's Consure Medical has pulled in an undisclosed investment from the India Innovation Fund and Indian Angel Network to launch a device designed to treat fecal incontinence, estimated to affect more than 16 million people in India and 100 million  worldwide. News

> Diagnostics firm Polymedco has signed a licensing deal to allow MedPrimex to sell its fecal immunochemical test for screening colorectal cancer in Mexico. Report

> Diagnostics firm GeneCentric is now officially launched, looking to market two lung cancer diagnostics using technologies licensed from the University of North Carolina at Chapel Hill. Release

> Medgenics ($MDGN) got regulatory approval in Israel to start clinical trials for Infradure, a tissue implant designed to treat hepatitis C. Item

Biotech News

 @FierceBiotech: XBiotech hatches big plans for Austin campus. Item | Follow @FierceBiotech

 @JohnCFierce: At long last, Ironwood gets its OK, shifts to commercialization alongside development. News | Follow @JohnCFierce

 @RyanMFierce: After reading through this OvaScience S-1, looks like VCs are in fact cashing out, some want to unload most of their shares. | Follow @RyanMFierce

> Cincy biotech spinoff snags $27M A round for vascular drug work. Story

> Novartis ready to present blockbuster COPD hopeful QVA149 to regulators. Article

> Teva's Neupogen-knockoff approval highlights slow progress of biosims. More

> J&J grabs Genmab's promising leukemia antibody in $1.1B deal. News

Pharma News

 @FiercePharma: Two drugmakers hit the Forbes "Fab 50" in Asia: Australia's CSL and India's Sun Pharma. Item | Follow @FiercePharma

> Novartis begs vets for loyalty through animal drug shortages. Article

> Avastin tops list of most-requested cancer meds in U.K. Report

> FDA flags cataract risk in kids using Vertex's Kalydeco. Story

Pharma Manufacturing News

 @EricPFierce: Hospira goes back to Orchid, picks up API plant, R&D center for $200 million. Good news tainted a bit by FDA warning. Story | Follow @EricPFierce

> Closed plants lead Novartis to plead for vet loyalty. Story

> Claris squares off against former partners in U.S. injectables market. Article

> Scots reject GSK wind turbines; tidal turbines up next. Story

Vaccines News

 @AlisonBFierce: What does AstraZeneca's new CEO mean to vaccinemaker MedImmune? More | Follow @AlisonBFierce

> S. Korea, Sweden partner up to find Alzheimer's vaccine. Item

> West Nile virus breaks out in the South. News

> CSL nets closeout letter after FDA violations. More

> Flu adjuvant adds promise to vaccine. Report

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.